PsiThera released STORMM 0.3.0, a major update to its next-gen, open-source, GPU-native molecular simulation engine.

PsiThera is a biotechnology company harnessing biologically relevant protein states and computational intelligence to create oral drugs for immune and inflammatory diseases — therapeutic areas long reliant on injectables. Integrating biophysics, computational modeling, and mechanistic biology enables PsiThera’s expert drug hunters to discover new therapeutic opportunities and optimized drugs. The company’s rapidly advancing pipeline focuses on high-value targets, starting with the Tumor Necrosis Factor (TNF) superfamily.